The results demonstrated that P4HA1 was upregulated in brain and CNS cancer, breast cancer, CRC, head and neck cancer, kidney cancer, lung cancer, pancreatic cancer, and SARC compared with the normal tissues (Supplementary Figure S5). This evidence concerns the gene P4HA1 and kidney cancer.